These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8572673

  • 1. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy.
    Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH.
    Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673
    [Abstract] [Full Text] [Related]

  • 2. Low single dose gabapentin does not affect prefrontal and occipital gamma-aminobutyric acid concentrations.
    Preuss N, van der Veen JW, Carlson PJ, Shen J, Hasler G.
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1708-13. PubMed ID: 24071367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
    Petroff OA, Hyder F, Rothman DL, Mattson RH.
    Epilepsia; 2006 Mar; 47(3):495-8. PubMed ID: 16529611
    [Abstract] [Full Text] [Related]

  • 5. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures.
    Petroff OA, Rothman DL, Behar KL, Hyder F, Mattson RH.
    Seizure; 1999 Apr; 8(2):120-7. PubMed ID: 10222306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanisms of action of gabapentin.
    Taylor CP.
    Rev Neurol (Paris); 1997 May; 153 Suppl 1():S39-45. PubMed ID: 9686247
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gabapentin (NEURONTIN)--a novel anticonvulsant.
    Murdoch LA.
    Axone; 1994 Dec; 16(2):56. PubMed ID: 7727298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and safety of gabapentin.
    Ramsay RE.
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [Abstract] [Full Text] [Related]

  • 16. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels.
    Bertrand S, Ng GY, Purisai MG, Wolfe SE, Severidt MW, Nouel D, Robitaille R, Low MJ, O'Neill GP, Metters K, Lacaille JC, Chronwall BM, Morris SJ.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):15-24. PubMed ID: 11408520
    [Abstract] [Full Text] [Related]

  • 17. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA, Mattson RH, Behar KL, Hyder F, Rothman DL.
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical actions of gabapentin in mouse brain.
    Leach JP, Sills GJ, Butler E, Forrest G, Thompson GG, Brodie MJ.
    Epilepsy Res; 1997 Jun; 27(3):175-80. PubMed ID: 9237051
    [Abstract] [Full Text] [Related]

  • 19. Gabapentin: pharmacokinetics, efficacy, and safety.
    Beydoun A, Uthman BM, Sackellares JC.
    Clin Neuropharmacol; 1995 Dec; 18(6):469-81. PubMed ID: 8681309
    [Abstract] [Full Text] [Related]

  • 20. Gabapentin. Antiepileptic mechanism of action.
    Kelly KM.
    Neuropsychobiology; 1998 Oct; 38(3):139-44. PubMed ID: 9778601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.